Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2

被引：49

作者：

Holst, JJ ^{[1
]}

机构：

[1] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark

来源：

REGULATORY PEPTIDES | 2000年 / 93卷 / 1-3期

关键词：

D O I：

10.1016/S0167-0115(00)00185-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：45 / 51

页数：7

共 77 条

[1] OXYNTOMODULIN (GLICENTIN-(33-69)) - PHARMACOKINETICS, BINDING TO LIVER-CELL MEMBRANES, EFFECTS ON ISOLATED PERFUSED PIG PANCREAS, AND SECRETION FROM ISOLATED PERFUSED LOWER SMALL-INTESTINE OF PIGS [J].

BALDISSERA, FGA ;

HOLST, JJ ;

KNUHTSEN, S ;

HILSTED, L ;

NIELSEN, OV .

REGULATORY PEPTIDES, 1988, 21 (1-2) :151-166

[2] ISOLATION OF GLUCAGON-37 (BIOACTIVE ENTEROGLUCAGON OXYNTOMODULIN) FROM PORCINE JEJUNO-ILEUM - CHARACTERIZATION OF THE PEPTIDE [J].

BATAILLE, D ;

TATEMOTO, K ;

GESPACH, C ;

JORNVALL, H ;

ROSSELIN, G ;

MUTT, V .

FEBS LETTERS, 1982, 146 (01) :79-86

[3] HAMSTER PREPROGLUCAGON CONTAINS THE SEQUENCE OF GLUCAGON AND 2 RELATED PEPTIDES [J].

BELL, GI ;

SANTERRE, RF ;

MULLENBACH, GT .

NATURE, 1983, 302 (5910) :716-718

[4] EXON DUPLICATION AND DIVERGENCE IN THE HUMAN PREPROGLUCAGON GENE [J].

BELL, GI ;

SANCHEZPESCADOR, R ;

LAYBOURN, PJ ;

NAJARIAN, RC .

NATURE, 1983, 304 (5924) :368-371

[5] GUT HORMONES IN ADAPTATION [J].

BLOOM, SR .

GUT, 1987, 28 :31-35

[6] Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis [J].

Boushey, RP ;

Yusta, B ;

Drucker, DJ .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (05) :E937-E947

[7] Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells [J].

Buteau, J ;

Roduit, R ;

Susini, S ;

Prentki, M .

DIABETOLOGIA, 1999, 42 (07) :856-864

[8] Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2 [J].

Chance, WT ;

FoleyNelson, T ;

Thomas, I ;

Balasubramaniam, A .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (02) :G559-G563

[9] BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS [J].

DEACON, CF ;

NAUCK, MA ;

TOFTNIELSEN, M ;

PRIDAL, L ;

WILLMS, B ;

HOLST, JJ .

DIABETES, 1995, 44 (09) :1126-1131

[10] DEGRADATION OF GLUCAGON-LIKE PEPTIDE-1 BY HUMAN PLASMA IN-VITRO YIELDS AN N-TERMINALLY TRUNCATED PEPTIDE THAT IS A MAJOR ENDOGENOUS METABOLITE IN-VIVO [J].

DEACON, CF ;

JOHNSEN, AH ;

HOLST, JJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :952-957

← 1 2 3 4 5 6 7 8 →